A team of scientists has introduced a microscopy approach that combines a magnetic field with polarized light to produce quantitative measurements for detecting malaria in blood samples. Malaria affects more than 200 million people each year and leads to over 600,000 deaths. Improving how quickly and accurately the disease is diagnosed remains important, especially in settings with limited resources.

The method is designed to reduce reliance on expert interpretation and eliminate the need for staining or chemical treatment of samples. According to Dickson Mwenda Kinyua of Kirinyaga University, who collaborated with researchers at the University of Cambridge, “Our method doesn’t require expert interpretation and works without needing to stain or chemically treat the sample, making testing more accessible and easier to perform consistently.” This simplicity could support earlier diagnosis and more consistent treatment decisions.

The technique focuses on hemozoin, a crystal formed when malaria parasites digest hemoglobin inside red blood cells. These crystals have distinct physical properties: they align in magnetic fields and interact with light differently depending on their orientation. By using these characteristics, the researchers created a system that not only detects malaria but also provides quantitative measurements.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

In practice, a blood sample is placed under a polarizing microscope while a controlled magnetic field is applied. The magnetic field causes any hemozoin crystals to rotate and align, which changes how they affect polarized light. These changes appear as variations in image intensity and contrast. The researchers then use ratiometric intensity analysis, comparing images taken before and after magnetic alignment, along with threshold-based segmentation to measure the signal. This allows them to link signal strength directly to hemozoin concentration.

Testing on blood samples with and without malaria showed that the signal consistently matched the amount of hemozoin present, demonstrating reliable detection and quantification. The method also offers the ability to identify where signals originate within a sample, addressing limitations of earlier approaches that only provided bulk measurements. As Kinyua, first author of the study published in Biomedical Optics Express, noted, “Our method not only makes it possible to see malaria but also allows more precise measurements and the potential to map its location in the sample.”

Future work will focus on clinical trials using a wider range of patient samples and comparing results with standard diagnostic techniques. The team is also working to simplify and speed up the system, with plans to incorporate image analysis and machine learning to further reduce the need for expert evaluation.